• 12352 Citations
  • 27 h-Index
1973 …2017

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

2017

A Retrospective Analysis of the First 41 mCRPC Patients with Bone Pain Treated with Radium-223 at the National Institute of Oncology in Hungary

Küronya, Z., Sinkovics, I., Ágoston, P., Bíró, K., Bodrogi, I., Böde, I., Dank, M., Gyergyay, F., Vajdics, T., Kolonics, Z., Nagyiványi, K., Rúzsa & Géczi, L., Jan 10 2017, (Accepted/In press) In : Pathology and Oncology Research. p. 1-7 7 p.

Research output: Contribution to journalArticle

2 Citations (Scopus)

Outcome of Restarted Sunitinib Treatment in Patients with Metastatic Renal Cell Carcinoma: a Retrospective Trial and Combined Case Reports from Literature

Nagyiványi, K., Budai, B., Küronya, Z., Gyergyay, F., Bíró, K., Bodrogi, I. & Géczi, L., Oct 30 2017, (Accepted/In press) In : Pathology and Oncology Research. p. 1-7 7 p.

Research output: Contribution to journalArticle

1 Citation (Scopus)
2016

Outcomes in Patients With Metastatic Renal Cell Carcinoma Who Develop Everolimus-Related Hyperglycemia and Hypercholesterolemia: Combined Subgroup Analyses of the RECORD-1 and REACT Trials

Bono, P., Oudard, S., Bodrogi, I., Hutson, T. E., Escudier, B., Machiels, J. P., Thompson, J. A., Figlin, R. A., Ravaud, A., Basaran, M., Porta, C., Bracarda, S., Brechenmacher, T., Lin, C., Voi, M., Grunwald, V. & Motzer, R. J., Oct 1 2016, In : Clinical Genitourinary Cancer. 14, 5, p. 406-414 9 p.

Research output: Contribution to journalArticle

6 Citations (Scopus)
2013

Áttétes vesedaganatos betegek pazopanibterápiá jával szerzett elsõ hazai tapasztalatok

Translated title of the contribution: First Hungarian experience with pazopanib therapy for patients with metastatic renal cancerAnikó, M., István, B., András, C., Magdolna, D., Lajos, G., Zsófia, K., László, M., Ágota, P., Miklós, S. & György, B., 2013, In : Magyar onkologia. 57, 3, p. 173-176 4 p.

Research output: Contribution to journalArticle

3 Citations (Scopus)
2012

An international expanded-access programme of everolimus: Addressing safety and efficacy in patients with metastatic renal cell carcinoma who progress after initial vascular endothelial growth factor receptor-tyrosine kinase inhibitor therapy

Grünwald, V., Karakiewicz, P. I., Bavbek, S. E., Miller, K., Machiels, J. P., Lee, S. H., Larkin, J., Bono, P., Rha, S. Y., Castellano, D., Blank, C. U., Knox, J. J., Hawkins, R., Anak, O., Rosamilia, M., Booth, J., Pirotta, N., Bodrogi, I., Romedi, M., Ferrandini, S. & 249 others, Rondinon, M., Pittman, K., Goldstein, D., Shapiro, J., Troon, S., Yip, D., Mainwaring, P., Zigeuner, R., Loidl, W., Greil, R. F., Schmidinger, M., De Grève, J., Rottey, S., Vermorken, J., Machiels, J., Gil, T., Gennigens, C., Roumeguere, T., Barrios, C., Mathias, C., Assi, H., Hotte, S., Karakiewicz, P., Knox, J., Spadafora, S., Wood, L., Zalewski, P., Mackensie, M., Bjarnason, G., Lalancette, A., Chan, A., Higgins, B., North, S., Soulieres, D., Asselah, J., Sperlich, C., Miller, W., Yadav, S., El-Maraghi, R., Godoy, J., Prausová, J., Katolicka, J., Petruzelka, L., Kiss, I., Bono, P., Lapela, M., Miller, K., Bergmann, L., Beck, J., Jäger, E., Kindler, M., Overkamp, F., Wirth, M., Hölzer, W., Gschwend, J., Stenzl, A., Gauler, T., Niederwieser, D., Marschner, N., Lück, A., Tessen, H., Eichelberg, C., Steiner, T., Goebell, P., Kettner, E., Bakhshandeh-Bath, A., Wilhelm, M., Schmitz, S., Jacob, A., Bierer, S., Kube, U., Staehler, M., Engel, E., Frambach, M., Schellenberger, U., Albers, P., Simon, J., Gleissler, M., Klotz, T., Repp, R., Kröning, H., Westermann, J., Rebmann, U., Brehmer, B., Niederle, N., Grund, C., Verpoort, K., Fonara, P., Rassweiler, J., Bamias, A., Fountzilas, G., Razis, E., Mouratidou, D., Georgoulias, V., Samantas, E., Bodrogi, I., Mangel, L., Szanto, J., Berger, R., Pe'er, A., Sella, A., Ben-Yosef, R., Nechushtan, H., Crinò, L., Bracarda, S., Ciuffreda, L., Graiff, C., Falcone, A., Roselli, M., Sternberg, C., Santoro, A., Ruggeri, E., Bearz, A., Venturini, M., Aglietta, M., Amadori, D., Di Costanzo, F., Bari, M., Gebbia, N., Conte, P., Bonetti, A., Bordonaro, R., Cascinu, S., Contu, A., Cruciani, G., Gasparro, D., Nardi, M., Lelli, G., Lo Re, G., Boccardo, F., Lorusso, V., Maiello, E., Manente, P., Passalacqua, R., Piantedosi, F., Porta, C., Sacco, C., Tondini, C., De Placido, S., Carteni, G., Dogliotto, L., Rosti, G., Milella, M., Roila, F., Amoroso, D., Farina, G., Al-Khatib, H., Lee, S., Kim, T., Ahn, J., Lim, H., Rha, S., Chung, I., Kim, J., Chung, J., Ghosn, M., Shameseddine, A., Lugo, R., Cabrera, P., Osanto, S., Groenewegen, G., Blank, C., van den Eertwegh, F., van Herpen, C., Oosting, S., Soetekouw, P., Lilleby, W., Klepp, O., Guren, T., Alcedo, J., Karlov, P., Nosov, D., Roman, L., Rusakov, I., Bazarbashi, S., Toh, C., Mardiak, J., Constenla, M., Solans, F. G. D. M., Maroto Ray, J., Bellmunt Mollins, J., Castellano, D., Duran Martinez, I., Mellado Gonzalez, B., Domenech Santasusana, M., Lopez-Brea Piqueras, M., Campillo Fuentes, J., Gonzalez Larriba, J., Luque Caro, R., Meana Garcia, A., Aparicio, L., Batista Lopez, N., Calderero Aragon, V., Valverde Morales, C., Figueiras, M., Contreras Ibanez, J., Gonzalez Billalabeitia, E., Estrada, E., Arranz, J., Lambea Sorrosal, J., Lozano, A., de Villena, M. C., Espinosa, E., Lopez, R., Perez Garcia, J., Laurell, A., Stierner, U., Cwikiel, M., Borner, M., Dietrich, P. Y., Rothermundt, C., Pu, Y., Chang, Y., Ou, Y., Chuang, C., Liao, Y., Srimuninnimit, V., Sriuranpong, V., Buyukberber, S., Yalcin, B., Goker, E., Yalcin, S., Geldart, T., Wagstaff, J., Nicholson, S., Chowdhury, S., Bahl, A., Jones, R., Azzabi, A., Chao, D., Fife, K., Hawkins, R., Mead, G., Nathan, P., Pandha, H., Hajdenberg, J., Gabrail, N., Nimeh, N., Logan, T., Flaig, T., Schraeder, R., Rini, B., O'Rourke, M., Alemany, C., Beck, J., Kessinger, A., Amin, A., Arriaga, M. & Rodriguez, J., Feb 2012, In : European Journal of Cancer. 48, 3, p. 324-332 9 p.

Research output: Contribution to journalArticle

77 Citations (Scopus)
2010

Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: A randomised open-label trial

De Bono, J. S., Oudard, S., Ozguroglu, M., Hansen, S., MacHiels, J. P., Kocak, I., Gravis, G., Bodrogi, I., MacKenzie, M. J., Shen, L., Roessner, M., Gupta, S. & Sartor, A. O., Oct 2 2010, In : The Lancet. 376, 9747, p. 1147-1154 8 p.

Research output: Contribution to journalArticle

2111 Citations (Scopus)

The international testicular cancer linkage consortium: A clinicopathologic descriptive analysis of 461 familial malignant testicular germ cell tumor kindred

Mai, P. L., Friedlander, M., Tucker, K., Phillips, K. A., Hogg, D., Jewett, M. A. S., Lohynska, R., Daugaard, G., Richard, S., Bonaïti-Pellié, C., Heidenreich, A., Albers, P., Bodrogi, I., Geczi, L., Olah, E., Daly, P. A., Guilford, P., Fosså, S. D., Heimdal, K., Liubchenko, L. & 13 others, Tjulandin, S. A., Stoll, H., Weber, W., Easton, D. F., Dudakia, D., Huddart, R., Stratton, M. R., Einhorn, L., Korde, L., Nathanson, K. L., Bishop, D. T., Rapley, E. A. & Greene, M. H., Sep 2010, In : Urologic Oncology: Seminars and Original Investigations. 28, 5, p. 492-499 8 p.

Research output: Contribution to journalArticle

27 Citations (Scopus)
2009

Áramszolgáltatás és térinformatika

Translated title of the contribution: Electric distribution and geografical information systemBodrogi, I., Jan 1 2009, In : Geodezia es Kartografia. 61, 3, p. 22-27 6 p.

Research output: Contribution to journalArticle

A randomized, double-blind, placebo-controlled phase II study of vandetanib plus docetaxel/prednisolone in patients with hormone-refractory prostate cancer

Horti, J., Widmark, A., Stenzl, A., Federico, M. H., Abratt, R. P., Sanders, N., Pover, G. M. & Bodrogi, I., Apr 1 2009, In : Cancer Biotherapy and Radiopharmaceuticals. 24, 2, p. 175-180 6 p.

Research output: Contribution to journalArticle

36 Citations (Scopus)

Metakrón penismetastasis rectum-adenocarcinomából

Translated title of the contribution: Metachronous metastasis to the penis from carcinoma of the rectum: Case reportKüronya, Z., Bodrogi, I., Lövey, J., Plótár, V., Manninger, S. & Pápai, Z., Sep 1 2009, In : Magyar onkologia. 53, 3, p. 263-266 4 p.

Research output: Contribution to journalShort survey

5 Citations (Scopus)

Multinational, double-blind, phase III study of prednisone and either satraplatin or placebo in patients with castrate-refractory prostate cancer progressing after prior chemotherapy: The SPARC trial

Sternberg, C. N., Petrylak, D. P., Sartor, O., Witjes, J. A., Demkow, T., Ferrero, J. M., Eymard, J. C., Falcon, S., Calabrò, F., James, N., Bodrogi, I., Harper, P., Wirth, M., Berry, W., Petrone, M. E., McKearn, T. J., Noursalehi, M., George, M. & Rozencweig, M., Nov 10 2009, In : Journal of Clinical Oncology. 27, 32, p. 5431-5438 8 p.

Research output: Contribution to journalArticle

252 Citations (Scopus)

Younger age-at-diagnosis for familial malignant testicular germ cell tumor

Mai, P. L., Chen, B. E., Tucker, K., Friedlander, M., Phillips, K. A., Hogg, D., Jewett, M. A. S., Bodrogi, I., Geczi, L., Olah, E., Heimdal, K., Fosså, S. D., Nathanson, K. L., Korde, L., Easton, D. F., Dudakia, D., Huddart, R., Stratton, M. R., Bishop, D. T., Rapley, E. A. & 1 others, Greene, M. H., Dec 1 2009, In : Familial Cancer. 8, 4, p. 451-456 6 p.

Research output: Contribution to journalArticle

12 Citations (Scopus)
2008

Analysis of the DND1 gene in men with sporadic and familial testicular germ cell tumors

Linger, R., Dudakia, D., Huddart, R., Tucker, K., Friedlander, M., Phillips, K. A., Hogg, D., Jewett, M. A. S., Lohynska, R., Daugaard, G., Richard, S., Chompret, A., Stoppa-Lyonnet, D., Bonaïti-Pellié, C., Heidenreich, A., Albers, P., Olah, E., Geczi, L., Bodrogi, I., Daly, P. A. & 17 others, Guilford, P., Fosså, S. D., Heimdal, K., Tjulandin, S. A., Liubchenko, L., Stoll, H., Weber, W., Einhorn, L., McMaster, M., Korde, L., Greene, M. H., Nathanson, K. L., Cortessis, V., Easton, D. F., Bishop, D. T., Stratton, M. R. & Rapley, E. A., Mar 1 2008, In : Genes Chromosomes and Cancer. 47, 3, p. 247-252 6 p.

Research output: Contribution to journalArticle

30 Citations (Scopus)

A phase II multicentre study of irinotecan (CPT 11) in combination with cisplatin (CDDP) in metastatic or locally advanced penile carcinoma (EORTC PROTOCOL 30992)

Theodore, C., Skoneczna, I., Bodrogi, I., Leahy, M., Kerst, J. M., Collette, L., Ven, K., Marréaud, S. & Oliver, R. D. T., Jul 2008, In : Annals of Oncology. 19, 7, p. 1304-1307 4 p.

Research output: Contribution to journalArticle

58 Citations (Scopus)
9 Citations (Scopus)

Corrigendum to: "European Consensus Conference on Diagnosis and Treatment of Germ Cell Cancer

Krege, S., Beyer, J., Souchon, R., Albers, P., Albrecht, W., Algaba, F., Bamberg, M., Bodrogi, I., Bokemeyer, C., Cavallin-Ståhl, E., Classen, J., Clemm, C., Cohn-Cedermark, G., Culine, S., Daugaard, G., De Mulder, P. H. M., De Santis, M., de Wit, M., de Wit, R., Derigs, H. G. & 63 others, Dieckmann, K. P., Dieing, A., Droz, J. P., Fenner, M., Fizazi, K., Flechon, A., Fosså, S. D., Garcia del Muro, X., Gauler, T., Geczi, L., Gerl, A., Germa-Lluch, J. R., Gillessen, S., Hartmann, J. T., Hartmann, M., Heidenreich, A., Hoeltl, W., Horwich, A., Huddart, R., Jewett, M., Joffe, J., Jones, W. G., Kisbenedek, L., Klepp, O., Kliesch, S., Koehrmann, K. U., Kollmannsberger, C., Kuczyk, M., Laguna, P., Galvis, O. L., Loy, V., Mason, M. D., Mead, G. M., Mueller, R., Nichols, C., Nicolai, N., Oliver, T., Ondrus, D., Oosterhof, G. O. N., Ares, L. P., Pizzocaro, G., Pont, J., Pottek, T., Powles, T., Rick, O., Rosti, G., Salvioni, R., Scheiderbauer, J., Schmelz, H. U., Schmidberger, H., Schmoll, H. J., Schrader, M., Sedlmayer, F., Skakkebaek, N. E., Sohaib, A., Tjulandin, S., Warde, P., Weinknecht, S., Weissbach, L., Wittekind, C., Winter, E., Wood, L. & von der Maase, H., Aug 2008, In : European Urology. 54, 2, 1 p.

Research output: Contribution to journalComment/debate

European Consensus Conference on Diagnosis and Treatment of Germ Cell Cancer: A Report of the Second Meeting of the European Germ Cell Cancer Consensus Group (EGCCCG): Part II

Krege, S., Beyer, J., Souchon, R., Albers, P., Albrecht, W., Algaba, F., Bamberg, M., Bodrogi, I., Bokemeyer, C., Cavallin-Ståhl, E., Classen, J., Clemm, C., Cohn-Cedermark, G., Culine, S., Daugaard, G., De Mulder, P. H. M., De Santis, M., de Wit, M., de Wit, R., Derigs, H. G. & 63 others, Dieckmann, K. P., Dieing, A., Droz, J. P., Fenner, M., Fizazi, K., Flechon, A., Fosså, S. D., Garcia del Muro, X., Gauler, T., Geczi, L., Gerl, A., Germa-Lluch, J. R., Gillessen, S., Hartmann, J. T., Hartmann, M., Heidenreich, A., Hoeltl, W., Horwich, A., Huddart, R., Jewett, M., Joffe, J., Jones, W. G., Kisbenedek, L., Klepp, O., Kliesch, S., Koehrmann, K. U., Kollmannsberger, C., Kuczyk, M., Laguna, P., Leiva Galvis, O., Loy, V., Mason, M. D., Mead, G. M., Mueller, R., Nichols, C., Nicolai, N., Oliver, T., Ondrus, D., Oosterhof, G. O. N., Paz-Ares, L., Pizzocaro, G., Pont, J., Pottek, T., Powles, T., Rick, O., Rosti, G., Salvioni, R., Scheiderbauer, J., Schmelz, H. U., Schmidberger, H., Schmoll, H. J., Schrader, M., Sedlmayer, F., Skakkebaek, N. E., Sohaib, A., Tjulandin, S., Warde, P., Weinknecht, S., Weissbach, L., Wittekind, C., Winter, E., Wood, L. & von der Maase, H., Mar 2008, In : European Urology. 53, 3, p. 497-513 17 p.

Research output: Contribution to journalReview article

209 Citations (Scopus)

European Consensus Conference on Diagnosis and Treatment of Germ Cell Cancer: A Report of the Second Meeting of the European Germ Cell Cancer Consensus group (EGCCCG): Part I

Krege, S., Beyer, J., Souchon, R., Albers, P., Albrecht, W., Algaba, F., Bamberg, M., Bodrogi, I., Bokemeyer, C., Cavallin-Ståhl, E., Classen, J., Clemm, C., Cohn-Cedermark, G., Culine, S., Daugaard, G., De Mulder, P. H. M., De Santis, M., de Wit, M., de Wit, R., Derigs, H. G. & 63 others, Dieckmann, K. P., Dieing, A., Droz, J. P., Fenner, M., Fizazi, K., Flechon, A., Fosså, S. D., Garcia del Muro, X., Gauler, T., Geczi, L., Gerl, A., Germa-Lluch, J. R., Gillessen, S., Hartmann, J. T., Hartmann, M., Heidenreich, A., Hoeltl, W., Horwich, A., Huddart, R., Jewett, M., Joffe, J., Jones, W. G., Kisbenedek, L., Klepp, O., Kliesch, S., Koehrmann, K. U., Kollmannsberger, C., Kuczyk, M., Laguna, P., Leiva Galvis, O., Loy, V., Mason, M. D., Mead, G. M., Mueller, R., Nichols, C., Nicolai, N., Oliver, T., Ondrus, D., Oosterhof, G. O. N., Paz Ares, L., Pizzocaro, G., Pont, J., Pottek, T., Powles, T., Rick, O., Rosti, G., Salvioni, R., Scheiderbauer, J., Schmelz, H. U., Schmidberger, H., Schmoll, H. J., Schrader, M., Sedlmayer, F., Skakkebaek, N. E., Sohaib, A., Tjulandin, S., Warde, P., Weinknecht, S., Weissbach, L., Wittekind, C., Winter, E., Wood, L. & von der Maase, H., Mar 2008, In : European Urology. 53, 3, p. 478-496 19 p.

Research output: Contribution to journalReview article

372 Citations (Scopus)

Phase I study of TZT-1027, a novel synthetic dolastatin 10 derivative, for the treatment of patients with non-small cell lung cancer

Horti, J., Juhasz, E., Monostori, Z., Maeda, K., Eckhardt, S. & Bodrogi, I., Jun 1 2008, In : Cancer Chemotherapy And Pharmacology. 62, 1, p. 173-180 8 p.

Research output: Contribution to journalArticle

26 Citations (Scopus)

Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma

Hudes, G., Carducci, M., Tomczak, P., Dutcher, J., Figlin, R., Kapoor, A., Staroslawska, E., Sosman, J., McDermott, D., Bodrogi, I., Kovacevic, Z., Lesovoy, V., Schmidt-Wolf, I. G., Barbarash, O., Gokmen, E., O'Toole, T., Lustgarten, S., Moore, L. & Motzer, R. J., Feb 1 2008, In : Journal of Urology. 179, 2, p. 497-498 2 p.

Research output: Contribution to journalComment/debate

2 Citations (Scopus)
2007

Angiogenezisgátlók hatása metasztatikus vesesejtes rákban

Translated title of the contribution: Effect of angiosuppressive agents on renal cell carcinomaBodrogi, I., Dec 1 2007, In : Magyar onkologia. 51, 2, p. 145-153 9 p.

Research output: Contribution to journalArticle

1 Citation (Scopus)

Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomised, double-blind phase III trial

Escudier, B., Pluzanska, A., Koralewski, P., Ravaud, A., Bracarda, S., Szczylik, C., Chevreau, C., Filipek, M., Melichar, B., Bajetta, E., Gorbunova, V., Bay, J. O., Bodrogi, I., Jagiello-Gruszfeld, A. & Moore, N., Dec 22 2007, In : Lancet. 370, 9605, p. 2103-2111 9 p.

Research output: Contribution to journalArticle

1871 Citations (Scopus)

Randomized, placebo-controlled phase II study of vandetanib plus docetaxel in previously treated non-small-cell lung cancer

Heymach, J. V., Johnson, B. E., Prager, D., Csada, E., Roubec, J., Pešek, M., Špásová, I., Belani, C. P., Bodrogi, I., Gadgeel, S., Kennedy, S. J., Hou, J. & Herbst, R. S., Sep 20 2007, In : Journal of Clinical Oncology. 25, 27, p. 4270-4277 8 p.

Research output: Contribution to journalArticle

263 Citations (Scopus)

Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma

Hudes, G., Carducci, M., Tomczak, P., Dutcher, J., Figlin, R., Kapoor, A., Staroslawska, E., Sosman, J., McDermott, D., Bodrogi, I., Kovacevic, Z., Lesovoy, V., Schmidt-Wolf, I. G. H., Barbarash, O., Gokmen, E., O'Toole, T., Lustgarten, S., Moore, L. & Motzer, R. J., May 31 2007, In : New England Journal of Medicine. 356, 22, p. 2271-2281 11 p.

Research output: Contribution to journalArticle

2989 Citations (Scopus)
2006

A világossejtes veserák célzott terápiá ja és molekuláris patológiai alapjai

Translated title of the contribution: Molecular pathology and targeted therapy of clear cell renal cancerTímár, J., Kopper, L. & Bodrogi, I., Dec 1 2006, In : Magyar onkologia. 50, 4, p. 309-314 6 p.

Research output: Contribution to journalArticle

5 Citations (Scopus)

Characteristics and risk factors of cisplatin-induced ototoxicity in testicular cancer patients detected by distorsion product otoacoustic emission

Biro, K., Noszek, L., Prekopp, P., Nagyiványi, K., Géczi, L., Gaudi, I. & Bodrogi, I., Jul 1 2006, In : Oncology. 70, 3, p. 177-184 8 p.

Research output: Contribution to journalArticle

40 Citations (Scopus)

Ciszplatinnal kezelt heretumoros betegek késoi hallá skárosodásának vizsgálata disztorziós otoakusztikus emissziós (DOAE) készülékkel

Translated title of the contribution: Detection of late ototoxic side effect of cisplatin by distorsion product otoacustic emission (DPOAE)Biró, K., Noszek, L., Prekopp, P., Nagyiványi, K., Géczi, L., Gaudi, I. & Bodrogi, I., Dec 1 2006, In : Magyar onkologia. 50, 4, p. 329-335 7 p.

Research output: Contribution to journalArticle

2 Citations (Scopus)

Genome-wide linkage screen for testicular germ cell tumour susceptibility loci

Crockford, G. P., Linger, R., Hockley, S., Dudakia, D., Johnson, L., Huddart, R., Tucker, K., Friedlander, M., Phillips, K. A., Hogg, D., Jewett, M. A. S., Lohynska, R., Daugaard, G., Richard, S., Chompret, A., Bonaïti-Pellié, C., Heidenreich, A., Albers, P., Olah, E., Geczi, L. & 23 others, Bodrogi, I., Ormiston, W. J., Daly, P. A., Guilford, P., Fosså, S. D., Heimdal, K., Tjulandin, S. A., Liubchenko, L., Stoll, H., Weber, W., Forman, D., Oliver, T., Einhorn, L., McMaster, M., Kramer, J., Greene, M. H., Weber, B. L., Nathanson, K. L., Cortessis, V., Easton, D. F., Bishop, D. T., Stratton, M. R. & Rapley, E. A., Feb 1 2006, In : Human molecular genetics. 15, 3, p. 443-451 9 p.

Research output: Contribution to journalArticle

106 Citations (Scopus)
2005
23 Citations (Scopus)

The Y deletion gr/gr and susceptibility to testicular germ cell tumor

Nathanson, K. L., Kanetsky, P. A., Hawes, R., Vaughn, D. J., Letrero, R., Tucker, K., Friedlander, M., Phillips, K. A., Hogg, D., Jewett, M. A. S., Lohynska, R., Daugaard, G., Richard, S., Chompret, A., Bonaïti-Pellié, C., Heidenreich, A., Olah, E., Geczi, L., Bodrogi, I., Ormiston, W. J. & 29 others, Daly, P. A., Oosterhuis, J. W., Gillis, A. J. M., Looijenga, L. H. J., Guilford, P., Fosså, S. D., Heimdal, K., Tjulandin, S. A., Liubchenko, L., Stoll, H., Weber, W., Rudd, M., Huddart, R., Crockford, G. P., Forman, D., Oliver, D. T., Einhorn, L., Weber, B. L., Kramer, J., McMaster, M., Greene, M. H., Pike, M., Cortessis, V., Chen, C., Schwartz, S. M., Bishop, D. T., Easton, D. F., Stratton, M. R. & Rapley, E. A., Dec 2005, In : American Journal of Human Genetics. 77, 6, p. 1034-1043 10 p.

Research output: Contribution to journalArticle

148 Citations (Scopus)
2004

Clinical relevance of HER-2/neu expression in germ-cell testicular tumors

Mándoky, L., Géczi, L., Bodrogi, I., Tóth, J., Csuka, O., Kásler, M. & Bak, M., Jul 1 2004, In : Anticancer research. 24, 4, p. 2219-2224 6 p.

Research output: Contribution to journalArticle

14 Citations (Scopus)

Csírasejtes heredaganatok HER-2/neu-expressziójának klinikai jelento″sége

Translated title of the contribution: Clinical relevance of HER-2/neu expression in germ-cell testicular tumorsLászló, M., Lajos, G., István, B., József, T. & Mihály, B., Dec 1 2004, In : Magyar Urologia. 16, 3, p. 143-150 8 p.

Research output: Contribution to journalArticle

European consensus on diagnosis and treatment of germ cell cancer: A report of the European Germ Cell Cancer Consensus Group (EGCCCG)

Schmoll, H. J., Souchon, R., Krege, S., Albers, P., Beyer, J., Kollmannsberger, C., Fossa, S. D., Skakkebaek, N. E., de Wit, R., Fizazi, K., Droz, J. P., Pizzocaro, G., Daugaard, G., de Mulder, P. H. M., Horwich, A., Oliver, T., Huddart, R., Rosti, G., Paz Ares, L., Pont, O. & 48 others, Hartmann, J. T., Aass, N., Algaba, F., Bamberg, M., Bodrogi, I., Bokemeyer, C., Classen, J., Clemm, S., Culine, S., de Wit, M., Derigs, H. G., Dieckmann, K. P., Flasshove, M., Garcia del Muro, X., Gerl, A., German-Lluch, J. R., Hartmann, M., Heidenreich, A., Hoeltl, W., Joffe, J., Jones, W., Kaiser, G., Klepp, O., Kliesch, S., Kisbenedek, L., Koehrmann, K. U., Kuczyk, M., Laguna, M. P., Leiva, O., Loy, V., Mason, M. D., Mead, G. M., Mueller, R. P., Nicolai, N., Oosterhof, G. O. N., Pottek, T., Rick, O., Schmidberger, H., Sedlmayer, F., Siegert, W., Studer, U., Tjulandin, S., von der Maase, H., Walz, P., Weinknecht, S., Weissbach, L., Winter, E. & Wittekind, C., Sep 1 2004, In : Annals of Oncology. 15, 9, p. 1377-1399 23 p.

Research output: Contribution to journalReview article

369 Citations (Scopus)

Expression and Prognostic Value of the Lung Resistance-related Protein (LRP) in Germ Cell Testicular Tumors

Mándoky, L., Géczi, L., Doleschall, Z., Bodrogi, I., Csuka, O., Kásler, M. & Bak, M., Mar 1 2004, In : Anticancer research. 24, 2 C, p. 1097-1104 8 p.

Research output: Contribution to journalArticle

6 Citations (Scopus)

HER-2/neu as a predictive marker in a population of advanced breast cancer patients randomly treated either with single-agent doxorubicin or single-agent docetaxel

Di Leo, A., Chan, S., Paesmans, M., Friedrichs, K., Pinter, T., Cocquyt, V., Murray, E., Bodrogi, I., Walpole, E., Lesperance, B., Korec, S., Crown, J., Simmonds, P., Von Minckwitz, G., Leroy, J. Y., Durbecq, V., Isola, J., Aapro, M., Piccart, M. J. & Larsimont, D., Aug 2004, In : Breast Cancer Research and Treatment. 86, 3, p. 197-206 10 p.

Research output: Contribution to journalArticle

55 Citations (Scopus)

Increased predisposition to cancer in brothers and offspring of testicular tumor patients

Gundy, S., Babosa, M., Baki, M. & Bodrogi, I., Jan 1 2004, In : Pathology and Oncology Research. 10, 4, p. 197-203 7 p.

Research output: Contribution to journalArticle

26 Citations (Scopus)

Somatic mutations of KIT in familial testicular germ cell tumours

Rapley, E. A., Hockley, S., Warren, W., Johnson, L., Huddart, R., Crockford, G., Forman, D., Leahy, M. G., Oliver, D. T., Tucker, K., Friedlander, M., Phillips, K. A., Hogg, D., Jewett, M. A. S., Lohynska, R., Daugaard, G., Richard, S., Heidenreich, A., Geczi, L., Bodrogi, I. & 19 others, Olah, E., Ormiston, W. J., Daly, P. A., Looijenga, L. H. J., Guilford, P., Aass, N., Fosså, S. D., Heimdal, K., Tjulandin, S. A., Liubchenko, L., Stoll, H., Weber, W., Einhorn, L., Weber, B. L., McMaster, M., Greene, M. H., Bishop, D. T., Easton, D. & Stratton, M. R., Jun 14 2004, In : British journal of cancer. 90, 12, p. 2397-2401 5 p.

Research output: Contribution to journalArticle

Open Access
74 Citations (Scopus)

Topoisomerase-IIα expression as a predictive marker in a population of advanced breast cancer patients randomly treated either with single-agent doxorubicin or single-agent docetaxel

Durbecq, V., Paesmans, M., Cardoso, F., Desmedt, C., Di Leo, A., Chan, S., Friedrichs, K., Pinter, T., Van Belle, S., Murray, E., Bodrogi, I., Walpole, E., Lesperance, B., Korec, S., Crown, J., Simmonds, P., Perren J., T. J., Leroy, J. Y., Rouas, G., Sotiriou, C. & 2 others, Piccart, M. & Larsimont, D., Oct 2004, In : Molecular Cancer Therapeutics. 3, 10, p. 1207-1214 8 p.

Research output: Contribution to journalArticle

92 Citations (Scopus)

Tüdometastasectomia során eltávolított több góc különbözo szöveti szerkezettel

Translated title of the contribution: Different histological findings in two lung metastasectomy specimens patientCzeyda-Pommersheim, F., Sulyok, Z., Ésik, O., Bodrogi, I., Péter, I. & Köves, I., Jan 1 2004, In : Orvosi hetilap. 145, 3, p. 139-145 7 p.

Research output: Contribution to journalArticle

2003

Expression of HER-2/neu in testicular tumors

Mandoky, L., Geczi, L., Bodrogi, I., Toth, J. & Bak, M., Jul 1 2003, In : Anticancer research. 23, 4, p. 3447-3451 5 p.

Research output: Contribution to journalArticle

20 Citations (Scopus)

Gemcitabin helye a lokálisan előrehaladott vagy metasztatikus húgyhólyagrák kezelésében

István, B., Jan 1 2003, In : Magyar onkologia. 47, 2, p. 198-203 6 p.

Research output: Contribution to journalArticle

Gemcitabin helye a lokálisan elôrehaladott vagy metasztatikus húgyhólyagrák kezelésében.

Translated title of the contribution: Role of gemcitabine/cisplatin in the treatment of advanced and metastatic bladder cancerBodrogi, I., 2003, In : Magyar onkologia. 47, 2, p. 198-203 6 p.

Research output: Contribution to journalReview article

HER-2/neu expresszió vizsgálata heredaganatokban

Translated title of the contribution: INvestigation of HER-2/neu expression in testicular tumoursLászló, M., Lajos, G., István, B., József, T. & Mihály, B., Dec 1 2003, In : Magyar Urologia. 15, 1, p. 13-19 7 p.

Research output: Contribution to journalArticle

33 Citations (Scopus)

A PET study on the characterization of partially reversible radiogenic lower motor neurone disease

Ésik, O., Lengyel, Z., Sáfrány, G., Vönöczky, K., Ágoston, P., Székely, J., Lengyel, E., Márián, T., Trón, L. & Bodrogi, I., Jan 1 2002, In : Spinal Cord. 40, 9, p. 468-473 6 p.

Research output: Contribution to journalArticle

7 Citations (Scopus)

Pozitronemissziós tomográfia a malignus heredaganatok vizsgálatában.

Translated title of the contribution: Positron emission tomography in the investigation of malignant testicular tumorsKálvin, B., Márián, T., Galuska, L., Szakáll, S., Géczi, L., Esik, O., Trón, L. & Bodrogi, I., May 26 2002, In : Orvosi hetilap. 143, 21 Suppl 3, p. 1286-1289 4 p.

Research output: Contribution to journalArticle

2 Citations (Scopus)
2001

Kétoldali csírasejt-típusú heredaganatok

Lajos, G., Gomez, F., Mihály, B. & István, B., Dec 1 2001, In : Magyar onkologia. 45, 5, p. 417-423 7 p.

Research output: Contribution to journalArticle

Three-year results of the first educational and early detection program for testicular cancer in Hungary

Géczi, L., Gomez, F., Horváth, Z., Bak, M., Kisbenedek, L. & Bodrogi, I., May 21 2001, In : Oncology. 60, 3, p. 228-234 7 p.

Research output: Contribution to journalArticle

16 Citations (Scopus)
2000

A heredaganatok korai diagnózisa

Translated title of the contribution: Early diagnosis of testicular cancerGéczi, L., Horváth, Z., Beczássy, E., Kisbenedek, L., Bak, M. & Bodrogi, I., Dec 1 2000, In : Magyar onkologia. 44, 4, p. 275-283 9 p.

Research output: Contribution to journalArticle

2 Citations (Scopus)